Albert Sabin(1906 — 1993)

Albert Sabin

États-Unis, Empire russe

6 min read

SciencesSocietyMédecin20th Century20th century, the golden age of virology and the great post-war vaccination campaigns

American physician and virologist of Polish origin. In the 1950s he developed the live attenuated oral vaccine against poliomyelitis, administered on a sugar cube, which made possible mass vaccination campaigns around the world.

Frequently asked questions

Albert Sabin (1906-1993) was the Polish-born American physician and virologist who developed the live attenuated oral polio vaccine, administered on a lump of sugar. The key takeaway is that this vaccine, easy to distribute and inexpensive, made possible the great mass vaccination campaigns around the world, leading up to the global eradication initiative launched by the WHO in 1988. Unlike his rival Jonas Salk, whose vaccine was injectable, Sabin made the ethical choice not to patent his discovery, making it accessible to everyone.

Key Facts

  • Born in 1906 in Białystok (Russian Empire, now Poland), emigrated to the United States in 1921
  • Developed the live attenuated oral vaccine against polio, tested on a large scale from 1957-1959
  • His oral vaccine (OPV) was approved in the United States in 1961, succeeding the injectable vaccine of Jonas Salk (1955)
  • Declined to patent his vaccine in order to make it accessible to as many people as possible
  • Died in 1993 in Washington; his vaccine is a cornerstone of the global eradication of polio

Works & Achievements

Live attenuated oral polio vaccine (Sabin vaccine) (1957-1961)

His major achievement: a vaccine swallowed on a sugar cube, cheap and easy to administer, which became the main tool of the worldwide polio eradication campaigns.

Selection of the attenuated strains of the three poliovirus types (1956)

Meticulous virology work that involved weakening the virus so it would immunize without causing illness.

Mass clinical trials in the Soviet Union (1959)

Vaccination of millions of Soviet children, the first large-scale demonstration of the oral vaccine's effectiveness.

Research on encephalitis and dengue vaccines (1940s)

During the Second World War, Sabin helped develop vaccines to protect American soldiers.

Waiving the vaccine patent (1960s)

A major ethical gesture: by refusing to patent his discovery, Sabin made it cheap and accessible to the entire world.

Leadership of the Weizmann Institute (1970-1972)

Sabin put his experience at the service of one of the world's great centers of scientific research.

Anecdotes

Albert Sabin was convinced that his oral vaccine, dropped onto a lump of sugar, was better than the injectable vaccine of his rival Jonas Salk. To prove it, he tested it on himself, on his own family, and on volunteer inmates in an Ohio prison.

Unable to test his vaccine on a large scale in the United States (where Salk's vaccine was already deployed), Sabin turned to the Soviet Union at the height of the Cold War. Millions of Soviet children were vaccinated in the late 1950s, proving the effectiveness of the oral vaccine.

Sabin refused to patent his vaccine so that it would remain cheap and accessible to the entire world. He believed his discovery was a gift to humanity and did not want to profit from it.

Sabin's vaccine, simple to administer since it was swallowed rather than injected, became the main weapon in the great worldwide campaigns to eradicate polio, such as the “national immunization days” organized in dozens of countries.

Born in Białystok in the Russian Empire (today in Poland), Sabin emigrated to the United States as a teenager and learned English. He paid for part of his medical studies himself and became one of the most influential virologists of the 20th century.

Primary Sources

Albert B. Sabin, “Oral Poliovirus Vaccine: History of its Development and Use”, Journal of Infectious Diseases (1985)
The live attenuated oral poliovirus vaccine offers the advantage of producing intestinal immunity and spreading naturally, enabling large-scale collective protection.
Albert B. Sabin, communication on the trials in the Soviet Union (1959-1960)
The trials conducted on several million children demonstrated the safety and effectiveness of the oral vaccine administered by mouth.
Albert B. Sabin & al., “Live, orally given poliovirus vaccine”, Journal of the American Medical Association (JAMA) (1960)
Oral administration of attenuated strains of all three types of poliovirus induces lasting immunity comparable to that of a natural infection, without causing the disease.

Key Places

Białystok (Poland)

Sabin's birthplace, then part of the Russian Empire. He spent his childhood there before his family emigrated.

New York University

Sabin studied medicine there and earned his degree in 1931. It was the starting point of his scientific career.

Children's Hospital Research Foundation, Cincinnati

Laboratory at the University of Cincinnati where Sabin developed his oral polio vaccine in the 1950s.

Moscow (Soviet Union)

Site of the mass trials of the oral vaccine in the late 1950s, which demonstrated its effectiveness on millions of children.

Weizmann Institute of Science, Rehovot (Israel)

Prestigious research center that Sabin directed beginning in 1970.

Arlington National Cemetery (Virginia)

Sabin's burial place, in tribute to his military service and his contribution to public health.

See also